is a major specialty chemicals company supplying benzene-based intermediates to pharma, agrochem, and polymers. Long-term contracts with global clients and backward integration support earnings visibility and margins. Capex over the last cycle is now entering monetization phase, aiding operating leverage. Key risks are cyclical demand in end industries, Chinese competition, and environmental compliance.

#WatchOutFor#FundamentalViews#TechnicalViews#Miscellaneous#EquityResearch

1,054 likes·41 comments